Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes
Open accessAbstract
Importance: Blood pressure (BP) is a known risk factor for overall mortality and cardiovascular (CV)-specific fatal and nonfatal outcomes. It is uncertain which BP index is most strongly associated with these outcomes. Objective: To evaluate the association of BP indexes with death and a composite CV event. Design, Setting, and Participants: Longitudinal population-based cohort study of 11 135 adults from Europe, Asia, and South America with baseline observations collected from May 1988 to May 2010 (last follow-ups, August 2006-October 2016). Exposures: Blood pressure measured by an observer or an automated office machine; measured for 24 hours, during the day or the night; and the dipping ratio (nighttime divided by daytime readings). Main Outcomes and Measures: Multivariable-adjusted hazard ratios (HRs) expressed the risk of death or a CV event associated with BP increments of 20/10 mm Hg. Cardiovascular events included CV mortality combined with nonfatal coronary events, heart failure, and stroke. Improvement in model performance was assessed by the change in the area under the curve (AUC). Results: Among 11 135 participants (median age, 54.7 years, 49.3% women), 2836 participants died (18.5 per 1000 person-years) and 2049 (13.4 per 1000 person-years) experienced a CV event over a median of 13.8 years of follow-up. Both end points were significantly associated with all single systolic BP indexes (P < .001). For nighttime systolic BP level, the HR for total mortality was 1.23 (95% CI, 1.17-1.28) and for CV events, 1.36 (95% CI, 1.30-1.43). For the 24-hour systolic BP level, the HR for total mortality was 1.22 (95% CI, 1.16-1.28) and for CV events, 1.45 (95% CI, 1.37-1.54). With adjustment for any of the other systolic BP indexes, the associations of nighttime and 24-hour systolic BP with the primary outcomes remained statistically significant (HRs ranging from 1.17 [95% CI, 1.10-1.25] to 1.87 [95% CI, 1.62-2.16]). Base models that included single systolic BP indexes yielded an AUC of 0.83 for mortality and 0.84 for the CV outcomes. Adding 24-hour or nighttime systolic BP to base models that included other BP indexes resulted in incremental improvements in the AUC of 0.0013 to 0.0027 for mortality and 0.0031 to 0.0075 for the composite CV outcome. Adding any systolic BP index to models already including nighttime or 24-hour systolic BP did not significantly improve model performance. These findings were consistent for diastolic BP. Conclusions and Relevance: In this population-based cohort study, higher 24-hour and nighttime blood pressure measurements were significantly associated with greater risks of death and a composite CV outcome, even after adjusting for other office-based or ambulatory blood pressure measurements. Thus, 24-hour and nighttime blood pressure may be considered optimal measurements for estimating CV risk, although statistically, model improvement compared with other blood pressure indexes was small.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies including a larger number of participants were mainly obtained by pooling databases from previous small studies.
“Moreover, studies including a larger number of participants were mainly obtained by pooling databases from previous small studies.4,8”
From Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients (2023) · cites this paper as [4]
Some but not all studies have suggested that nighttime blood pressure is the strongest predictor of death.
“Some 4,6,9,11 but not all studies 5,10 have suggested that nighttime blood pressure is the strongest predictor of death.”
From Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients (2023) · cites this paper as [4]
The superiority of nighttime blood pressure over daytime blood pressure has been observed in other previous studies.
“The superiority of nighttime blood pressure over daytime blood pressure has been observed in other previous studies, 4,9,11,13,14,35,36”
From Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients (2023) · cites this paper as [4]
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305 · see citing works
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286 · see citing works
Self-citationGBD 2010: design, definitions, and metrics
Murray, C. J., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., Michaud, C., Naghavi, M., Salomon, J. A., Shibuya, K., Vos, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61899-6 · Cited by 1,103 · see citing works
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
(2014) · Hypertension Research · doi:10.1038/hr.2014.20 · Cited by 1,049 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473 · see citing works
Self-citationStergiou, G. S., Palatini, P., Parati, G., O’Brien, E., Januszewicz, A., Lurbe, E., Persu, A., Mancia, G., Kreutz, R., & on behalf of the European Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002843 · Cited by 859 · see citing works
Self-citationBöhm, M., Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K., Pocock, S., Konstantinidis, D., Choi, J. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30554-7 · Cited by 606 · see citing works
Staplin, N., de la Sierra, A., Ruilope, L. M., Emberson, J. R., Vinyoles, E., Gorostidi, M., Ruiz-Hurtado, G., Segura, J., Baigent, C., & Williams, B. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00733-x · Cited by 290 · see citing works
Barbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad054 · Cited by 188 · see citing works
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
Kandzari, D. E., Townsend, R. R., Kario, K., Mahfoud, F., Weber, M. A., Schmieder, R. E., Pocock, S., Tsioufis, K., Konstantinidis, D., Choi, J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.045 · Cited by 124 · see citing works
Cuffless Blood Pressure Monitoring: Promises and Challenges
Pandit, J. A., Lores, E., & Batlle, D. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03680320 · Cited by 101 · see citing works
Ogoyama, Y., Tada, K., Abe, M., Nanto, S., Shibata, H., Mukoyama, M., Kai, H., Arima, H., & Kario, K. (2022) · Hypertension Research · doi:10.1038/s41440-021-00761-8 · Cited by 59 · see citing works
Lee, E. K., Poon, P., Yu, C., Lee, V. W., Chung, V. C., & Wong, S. Y. (2022) · The Journal of Clinical Hypertension · doi:10.1111/jch.14482 · Cited by 38 · see citing works
Melgarejo, J. D., Maestre, G. E., Mena, L. J., Lee, J. H., Petitto, M., Chávez, C. A., Calmon, G., Silva, E., Thijs, L., Al-Aswad, L. A., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00687-1 · Cited by 11 · see citing works
Self-citation
- Authors
- Yang, W.-Y., Melgarejo, J. D., Thijs, L., Zhang, Z.-Y., Boggia, J., Wei, F.-F., Hansen, T. W., Asayama, K., Ohkubo, T., Jeppesen, J., Dolan, E., Stolarz-Skrzypek, K., Malyutina, S., Casiglia, E., Lind, L., Filipovský, J., Maestre, G. E., Li, Y., Wang, J.-G., Imai, Y., Kawecka-Jaszcz, K., Sandoya, E., Narkiewicz, K., O’Brien, E., Verhamme, P., Staessen, J. A., & for The International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators
- Affiliations
- Shanghai Jiao Tong University (CN)
- Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela
- KU Leuven (BE)
- Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay
- Steno Diabetes Center Copenhagen (DK)
- Tohoku Institute for Management of Blood Pressure (JP)
- University of Copenhagen (DK)
- Addenbrooke's Hospital (GB)
- The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland
- Institute of Cytology and Genetics (RU)
- University of Padua (IT)
- Uppsala University (SE)
- Charles University (CZ)
- Universidad del Zulia (VE)
- Asociación Española Primera en Salud, Montevideo, Uruguay
- Gdańsk Medical University (PL)
- Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
- Maastricht University (NL)
- Corresponding author
- Staessen, Jan A.
- ORCID
- Yang, Wen-Yi
- Thijs, Lutgarde
- Zhang, Zhen-Yu
- Wei, Fang-Fei
- Hansen, Tine W.
- Asayama, Kei
- Ohkubo, Takayoshi
- Jeppesen, Jørgen
- Dolan, Eamon
- Malyutina, Sofia
- Casiglia, Edoardo
- Lind, Lars
- Filipovský, Jan
- Maestre, Gladys E.
- Li, Yan
- Wang, Ji-Guang
- Imai, Yutaka
- Sandoya, Edgardo
- Narkiewicz, Krzysztof
- Verhamme, Peter
- Staessen, Jan A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2019-08-06
- Volume
- 322
- Issue
- 5
- Pages
- 409
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6822661
- OpenAlex
- W2966011904
- Cited by
- 491
- References
- 5
- Citations by year
- 2026: 47 · 2025: 74 · 2024: 85 · 2023: 75 · 2022: 63 · 2021: 71 · 2020: 63 · 2019: 13
- FWCI
- 37.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Lirias (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, other-oa)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion)
- ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley) (submittedVersion)
- Funders
- Pfizer (15XD1503200)
- Univerzita Karlova v Praze
- Hjerteforeningen (01-2-9-9A-22914)
- Showa Pharmaceutical University
- Steno Diabetes Center Copenhagen (SDCC 3.A Complications)
- European Commission (LSHM-CT-2006-037093, G.0881.13, 201550, 713601, 2011-294713-EPLORE, 305507)
- National Natural Science Foundation of China (91639203, 81170245, 81470533, 81270373, 2013CB530700)
- Fundacja na rzecz Nauki Polskiej
- Fonds Wetenschappelijk Onderzoek (G.0881.13)
- Ministry of Agriculture, Forestry and Fisheries (NouEi 2-02)
- Fondo Nacional de Ciencia Tecnología e Innovación (R01AG036469, G‐97000726)
- Vlaamse regering
- H. Lundbeck A/S
- National Institutes of Health (G-97000726)
- Pfizer Japan
- Chugai Pharmaceutical
- Japan Society for the Promotion of Science (16K15359, 17H04126)
- National Institute on Aging (R01AG036469, R03AG054186, P30AG066546)
- Fogarty International Center
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- blood pressure, ambulatory blood pressure, office blood pressure, 24-hour ambulatory blood pressure, nocturnal blood pressure, systolic blood pressure, cardiovascular mortality, cardiovascular events, heart failure, stroke, coronary events, cardiovascular risk prediction, cardiovascular risk score
- MeSH terms
- Adult, Blood Pressure, Blood Pressure Determination, Cardiovascular Diseases, Circadian Rhythm, Female, Humans, Hypertension, Longitudinal Studies, Male, Middle Aged, Risk Factors, Proportional Hazards Models, Blood Pressure Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review